Skip to main content Skip to search

Mandala Collections Sources

Found 6 results
Filters: Author is Lewis, Glyn  [Clear All Filters]
2015
Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, Kessler D, Lewis G, Watkins E, Morant N, Taylor RS et al..  2015.  The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study). Health Technology Assessment. 19(73):1-124.
Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, Kessler D, Lewis G, Watkins E, Brejcha C, Cardy J et al..  2015.  Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. The Lancet. 386(9988):63-73.
Rice F, Rawal A, Riglin L, Lewis G, Lewis G, Dunsmuir S.  2015.  Examining reward-seeking, negative self-beliefs and over-general autobiographical memory as mechanisms of change in classroom prevention programs for adolescent depression. Journal of Affective Disorders. 186:320-327.
2014
Kuyken W, Byford S, Byng R, Dalgleish T, Lewis G, Taylor R, Watkins ER, Hayes R, Lanham P, Kessler D et al..  2014.  Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial. Trials. 15(1)
2010
Hunot V, Moore THM, Caldwell D, Davies P, Jones H, Lewis G, Churchill R.  2010.  Mindfulness-based 'third wave' cognitive and behavioural therapies versus other psychological therapies for depression. Cochrane Database of Systematic Reviews.
Kuyken W, Byford S, Byng R, Dalgleish T, Lewis G, Taylor R, Watkins ER, Hayes R, Lanham P, Kessler D et al..  2010.  Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial. Trials. 11(1)